Evidence map›Paper›PMID 21278831›Full record

ArticleSleep medicine clinics2010

Neuropharmacology of Sleep and Wakefulness.

Christopher J Watson, Helen A Baghdoyan, Ralph Lydic

Abstract read
In one paragraph

Article in Sleep medicine clinics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Sleep, Neural Circulatory Control, and Cardiovascular Disease: A Mechanistic Review.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Research on the Improvement Effects and Mechanisms ofJournal of microbiology and biotechnology · 2025
    Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Restoring consciousness with pharmacologic therapy: Mechanisms, targets, and future directions.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Christopher J WatsonDepartment of Anesthesiology, University of Michigan, Ann Arbor, MI, U.S.A.
Helen A Baghdoyan
Ralph Lydic

Funding

CHOLINERGIC MECHANISMS OF REM SLEEP GENERATIONR37MH045361 · NIMH · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI BAGHDOYAN, HELEN A · 2004 to 2013
$3.4M
CHOLINERGIC MECHANISMS OF BREATHING DURING SLEEPR01HL040881 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LYDIC, RALPH · 1989 to 2010
$3.3M
CHOLINERGIC PHENOTYPE IN MURINE MODELS OF SLEEPR01HL065272 · NHLBI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI LYDIC, RALPH · 1999 to 2013
$3.2M
OPIOID INDUCED REM SLEEP INHIBITIONR01HL057120 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LYDIC, RALPH · 1997 to 2005
$2.0M
CHOLINERGIC MECHANISMS OF REM SLEEP GENERATIONR01MH045361 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BAGHDOYAN, HELEN A · 1994 to 2003
$807k
NHLBI NIH HHS R01 HL040881NHLBI NIH HHS R01 HL057120NHLBI NIH HHS R01 HL065272NIMH NIH HHS R01 MH045361NIMH NIH HHS R37 MH045361
6 · The paper itself

Abstract

The development of sedative/hypnotic molecules has been empiric rather than rational. The empiric approach has produced clinically useful drugs but for no drug is the mechanism of action completely understood. All available sedative/hypnotic medications have unwanted side effects and none of these medications creates a sleep architecture that is identical to the architecture of naturally occurring sleep. This chapter reviews recent advances in research aiming to elucidate the neurochemical mechanisms regulating sleep and wakefulness. One promise of rational drug design is that understanding the mechanisms of sedative/hypnotic action will significantly enhance drug safety and efficacy.

Identifiers

PMID21278831
PMCPMC3026477

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.